Alteration in ocular function induced by phenylethylamine analogs of dopamine

References

• Weiner N. Norepinephrine, epinephrine and the sympathomimetic amines. The Pharmacological Basis of Therapeutics, A. G. Gilman, L. S. Goodman, A. Gilman. Macmillan Publishing Co., Inc., New York 1980; 155
   Google Scholar
• Verplanken P. A., Buylaert W. A., Bogaert M. G. Effects of dopamine and apomorphine on the response of rabbit isolated atria to sympathetic nerve stimulation. Naun.-Schmied. Arch. Pharmacol. 1983; 323: 45–48
   Google Scholar
• Shannon R. P., Mead A., Sears M. L. The effect of dopamine on the intraocular pressure and pupil of the rabbit eye. Invest. Ophthal. 1976; 15: 371–380
   PubMedGoogle Scholar
• Macri F. J., Cevario S. J. The inhibitor actions of dopamine, hydroxyamphetamine and phenylephrine on aqueous humor formation, Exp. Eye Res. 1978; 26: 85–89
   PubMed Web of Science ®Google Scholar
• Green D., Hensley A., Lollis G. Dopamine stimulation of passive permeability and secretion in the isolated rabbit ciliary epithelium. Exp. Eye Res. 1979; 29: 423–427
   PubMed Web of Science ®Google Scholar
• Chiou G. C.Y., Chiou F. Y. Dopaminergic involvement in intraocular pressure in the rabbit eye. Ophthal. Res. 1983; 15: 131–135
   PubMed Web of Science ®Google Scholar
• Watanabe K., Chiou G. C.Y. Action Mechanism of timolol to lower intraocular pressure in rabbits. Ophthal. Res. 1983; 15: 160–167
   PubMed Web of Science ®Google Scholar
• Vareilles P., Lotti V. S. Effect of timolol on aqueous humor dynamics in the rabbit. Ophthal. Res. 1981; 13: 72–79
   Web of Science ®Google Scholar
• van Rossum J. M. Different types of sympathomimetic a-receptors. J. Pharm. Pharmacol. 1965; 17: 202–216
   PubMed Web of Science ®Google Scholar
• Tsai T. H., Langer S. Z., Trendelenberg U. Effects of dopamine and a-methyldopamine on smooth muscle and on the cardiac pacemaker. J. Pharmacol. Exp. Ther. 1967; 156: 310–324
   PubMed Web of Science ®Google Scholar
• Potter D. E., Rowland J. M. Adrenergic drugs and intraocular pressure: effects of selective β-adrenergic agonists. Exp. Eye Res. 1978; 27: 615–625
   PubMed Web of Science ®Google Scholar
• Rowland J. M., Potter D. E. Adrenergic drugs and intraocular pressure: the hypertensive effect of epinephrine. Ophthal. Res. 1980; 12: 221–229
   Web of Science ®Google Scholar
• Inemee H. C., van Zwieten P. A. An increase in intraocular pressure due to clonidine. Graefes Arch. clin. exp. Ophthal. 1978; 207: 149–156
   Google Scholar
• Siedehamel R. J., Tye A., Patil P. N. An analysis of ephedrine mydriasis in relationship to iris pigmentation in the gunea pig eye in vitro. J. Pharmacol. Exp. Ther. 1970; 171: 205–213
   PubMed Web of Science ®Google Scholar
• Kohli J. D., Goldberg L. I., Volkman P. H., Cannon J. G. N,N-di-n-propyl-dopamine: a qualitatively different dopamine vascular agonist. J. Pharmacol. Exp. Ther. 1978; 207: 16–22
   PubMed Web of Science ®Google Scholar
• Libet B., Tosaka T. Dopamine as a synaptic transmitter and modulator in sympathetic ganglia. Proc. Nat. Acad. Sci. 1970; 67: 667–673
   PubMed Web of Science ®Google Scholar
• Enero M. A., Langer S. Z. Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naun.-Schmied. Arch. Pharmacol. 1975; 289: 179–203
   Google Scholar
• Cavero, II., Lefévre-Borg F., Gomerie R. Heart rate lowering effects of N,N-di-n-propyldopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow. J. Pharmacol. Exp. Ther. 1981; 219: 510–519
   PubMed Web of Science ®Google Scholar
• Kohli J. D., Listinsly J. L., Goldberg L. I. The inhibitory neurogenic effects of N.N-di-n-propyldopamine: a vascular dopamine agonist. Advances in bio-science: Peripheral Dopamine Receptors, J. L. Imbs, J. Schwartz. Pergamon Press, Oxford 1979; Vol. 20: 249–255
   Google Scholar
• Massingham R., Dubocovich M. L., Langer S. Z. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog. Naun. Schmied. Arch. Pharmacol. 1980; 314: 17–28
   Google Scholar
• Potter D. E., Burke J. A. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Current Eye Res. 1982; 2: 281–288
   PubMed Web of Science ®Google Scholar
• Mekki Q. A., Hassan S. M., Turner P. Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet 1983; 1: 1250–1251
   PubMed Web of Science ®Google Scholar
• Lustig A. Versfärkt Bromocriptin die Wirkung augeninnendrucksenkender Mittel?. Dtsch. Med. Wochenschr. 1983; 108: 1656–1657
   PubMedGoogle Scholar